Events

KFF hosted CDC Director Dr. Rochelle Walensky for a discussion focused on the status of COVID-19, the CDC’s priorities for the future, including the agency’s recent reorganization and other potential reforms, and how CDC is considering the health implications of climate change. Dr. Drew Altman, president and CEO of KFF, made introductory…

Medicare Advantage is the rapidly growing private plan alternative to traditional Medicare that provides coverage to approximately half of Medicare beneficiaries. Controversy has arisen over a Biden Administration proposal for changes to payments to insurers for the coming year, including how the health risk of enrollees is captured, as well…

A Look at Eligibility, Enrollment, and Renewal Policies in Place in Early 2023 KFF estimates that enrollment in Medicaid and the Children’s Health Insurance Program (CHIP) will have grown by 23.3 million enrollees, to nearly 95 million, by the end of March, when the federal continuous enrollment provision expires. Starting…

The Supreme Court’s decision to overturn Roe v. Wade and subsequent state abortion bans have moved the issue of access to high-quality and affordable contraceptive care to the forefront. As these seismic shifts shape women’s health care in the United States, the FDA is considering an application for a daily…

With the November midterm elections comes changes in Congress and state legislatures. While full election results remain in flux, there is the possibility of a shift from unified Democratic control of the White House and Congress to divided power. A split in political control of the federal government raises big…

The COVID-19 pandemic has driven record rises in Medicaid enrollment and substantial increases in total Medicaid spending. The forthcoming end of the Public Health Emergency — and the subsequent unwinding of additional federal funding for Medicaid and the requirement for continuous coverage — are expected to increase state costs and…

The era of government-financed COVID tests, vaccines, and therapeutics is likely coming to an end soon. In August, the Administration announced that by January 2023, it expects to end its purchase and distribution of COVID vaccines, citing a lack of federal funds. The announcement signals the shift in the United…

The covid-19 pandemic continues to cast a long shadow over the lives of older adults and their family caregivers in the United States, even as many Americans resolve to move on and resume normal activities. Even President Joe Biden declared “the pandemic is over,” in a recent interview, a controversial…

As the 2022 mid-term elections approach, inflation and gas prices are on the top of voters’ minds. While health care prices have often risen faster than the rest of the economy, the prices for medical services are generally set in advance – often tied to the calendar year – creating…

The Inflation Reduction Act includes several landmark health care provisions that would lower prescription drug costs for people with Medicare, reduce Medicare drug spending and extend enhanced subsidies for Affordable Care Act marketplace coverage. On Thursday, August 11, a panel of KFF experts held a web briefing to explain these…